TETAGAM-P

This brand name is authorized in Austria, Estonia, Hong Kong, Ireland, Malta, Romania, Tunisia, Turkey, South Africa

Active ingredients

The drug TETAGAM-P contains one active pharmaceutical ingredient (API):

1 Immunoglobulin human anti-tetanus UNII V4SWI4RF4J - HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN

Human tetanus immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against the toxin produced by the bacteria clostridium tetanus. Read about Tetanus immunoglobulin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TETAGAM-P Solution for injection	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06BB02	Tetanus immunoglobulin	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins
Discover more medicines within J06BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1253113, 1638637
Country: HK	Department of Health Drug Office	Identifier(s): 51935
Country: MT	Medicines Authority	Identifier(s): MA665/00801, MA665/00802
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67888001
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 8143032, 8143033
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681624980170
Country: ZA	Health Products Regulatory Authority	Identifier(s): T/30.2/0743, T/30.2/0744